Akums Drugs and Pharmaceutical (AKUMS) — Net Asset Momentum
Akums Drugs and Pharmaceutical (AKUMS) recorded a net asset momentum of 325.2% as of March 2025, with net assets of Rs30.64 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See how many days can Akums Drugs and Pharmaceutical fund operations to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Akums Drugs and Pharmaceutical Net Asset Momentum (2022–2025)
This chart tracks Akums Drugs and Pharmaceutical's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +325.2%, with net assets of Rs30.64 Billion INR as of March 2025. Read Akums Drugs and Pharmaceutical (AKUMS) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for Akums Drugs and Pharmaceutical (2022–2025)
The table below shows the complete annual net asset history for Akums Drugs and Pharmaceutical from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of Akums Drugs and Pharmaceutical.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +325.2% |
| 2024 | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -0.4% |
| 2023 | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +15.7% |
| 2022 | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |